What is the treatment for Klebsiella (a type of bacteria) ear infection?

From the Guidelines

Klebsiella ear infections require prompt antibiotic treatment, typically with fluoroquinolones like ciprofloxacin ear drops (0.3%), applied 4 drops to the affected ear twice daily for 7-10 days. For more severe infections, oral antibiotics may be necessary, such as amoxicillin-clavulanate (875/125 mg twice daily for 7-10 days) or levofloxacin (750 mg once daily for 5-7 days) 1. The choice of empiric antibiotic regimens in patients with ear infections should be based on the clinical condition of the patients, the individual risk for infection by resistant pathogens, and the local resistance epidemiology 1. It is essential to keep the ear dry during treatment by avoiding swimming and using a cotton ball with petroleum jelly during showers. Clean the outer ear gently with a warm washcloth, but don't insert anything into the ear canal. Complete the full course of antibiotics even if symptoms improve. Klebsiella pneumoniae is a gram-negative bacterium that can cause particularly stubborn ear infections because it forms a protective capsule and may have antibiotic resistance 1. If symptoms worsen or don't improve within 48-72 hours of treatment, seek medical attention as drainage, culture, and sensitivity testing may be needed to determine the most effective antibiotic. Pain can be managed with over-the-counter medications like acetaminophen or ibuprofen following package directions. In the context of ear infections, the main resistance problem is posed by ESBL-producing Enterobacteriaceae, which are prevalent in hospital-acquired infections but observed in community-acquired infections too 1. Specific risk factors for ESBL-producing bacteria in community-acquired infections include recent exposure to antibiotics (particularly third generation cephalosporins or fluoroquinolones) within 90 days of infection or known colonization with ESBL producing Enterobacteriaceae 1. The acquisition of antibiotic resistance by Klebsiella pneumoniae has seriously affected the treatment and control of these organisms, and affected patients usually have multiple and relevant co-morbidities, with prolonged hospital stay and received long courses of broad-spectrum antibiotics 1. Therefore, a rational and appropriate use of antibiotics is particularly important both to optimize quality clinical care and to reduce selection pressure on resistant pathogens 1. Some strategies aiming at achieving optimal use of antimicrobial agents have been described, but it is essential that clinicians know antibiotic administration minimal requirements 1. Without these minimal requirements, clinicians worldwide will increase the likelihood of treatment failures and antibiotic resistance. The recent challenges of treating multidrug-resistant gram-negative infections, especially in critically ill patients, have renewed interest in the use of “old” antibiotics such as polymyxins and fosfomycin 1, now routinely used for treatment of MDR bacteria in critical ill patients. New antibiotics such as ceftolozone/tazobactam and ceftazidime/avibactam have been approved for treatment of complicated infections (in combination with metronidazole) including infection by ESBLs producing Enterobacteriaceae and P. aeruginosa 1. These antimicrobials will be valuable for treating infections caused by MDR gram-negative bacteria in order to preserve carbapenems. However, the use of these antibiotics should be limited to preserve their activity and prevent the emergence of resistance. In the setting of ear infections, empiric antimicrobial therapy should be started as soon as possible in patients with organ dysfunction and septic shock 1. The selection of a pharmacological agent with penetration to the site of presumed infection is necessary, and the pathophysiological and immunological status of the patient and the pharmacokinetic properties of the chosen drugs warrant consideration. In critically ill patients, higher than standard loading doses of hydrophilic antimicrobials such as beta-lactams should be administered to ensure optimal exposure at the infection site independently of the patient’s renal function because of the dilution effect 1. Two patterns of bactericidal activity have been described for antibiotics: time-dependent activity and concentration-dependent activity, and the efficacy of time-dependent antibacterial agents in severely ill patients is related primarily to the maintenance of supra-inhibitory concentrations, and therefore, multiple daily dosing or continuous infusion may be appropriate 1. On the other hand, some agents including aminoglycosides have concentration-dependent activity; therefore, for this antibiotic class, the entire daily dose should be administered in a once daily way (or with the lowest possible number of daily administrations) to achieve the highest peak plasma level and reduce the renal cortex exposure to aminoglycosides and reduces the risk of nephrotoxicity 1. In patients with uncomplicated ear infections, single doses have the same impact as multiple doses and post-operative antimicrobial therapy is not necessary if source control is adequate 1. In the setting of complicated ear infections, a short course of antibiotic therapy (3–5 days) after adequate source control is a reasonable option 1. However, in critically ill patients with ongoing sepsis, an individualized approach should be always mandatory and patient’s inflammatory response should be monitored regularly 1 and decisions to continue, narrow, or stop antimicrobial therapy must be made on the basis of clinician judgment. Patients who have ongoing signs of peritonitis or systemic illness beyond 5–7 days of antibiotic treatment normally warrant a diagnostic investigation to determine whether additional surgical intervention is necessary to address an ongoing uncontrolled source of infection or antimicrobial treatment failure 1. The prolonged and inappropriate use of antibiotics appears a key factor in the rapid rise of antimicrobial resistance worldwide over the past decade 1. A rational and appropriate use of antibiotics is particularly important both to optimize quality clinical care and to reduce selection pressure on resistant pathogens. Several strategies aiming at achieving optimal use of antimicrobial agents have been described, but it is essential that clinicians know antibiotic administration minimal requirements. Without these minimal requirements, clinicians worldwide will increase the likelihood of treatment failures and antibiotic resistance. In the context of ear infections, the choice of empiric antibiotic regimens should be based on the clinical condition of the patients, the individual risk for infection by resistant pathogens, and the local resistance epidemiology 1. The recent challenges of treating multidrug-resistant gram-negative infections, especially in critically ill patients, have renewed interest in the use of “old” antibiotics such as polymyxins and fosfomycin 1, now routinely used for treatment of MDR bacteria in critical ill patients. New antibiotics such as ceftolozone/tazobactam and ceftazidime/avibactam have been approved for treatment of complicated infections (in combination with metronidazole) including infection by ESBLs producing Enterobacteriaceae and P. aeruginosa 1. These antimicrobials will be valuable for treating infections caused by MDR gram-negative bacteria in order to preserve carbapenems. However, the use of these antibiotics should be limited to preserve their activity and prevent the emergence of resistance. In the setting of ear infections, empiric antimicrobial therapy should be started as soon as possible in patients with organ dysfunction and septic shock 1. The selection of a pharmacological agent with penetration to the site of presumed infection is necessary, and the pathophysiological and immunological status of the patient and the pharmacokinetic properties of the chosen drugs warrant consideration. In critically ill patients, higher than standard loading doses of hydrophilic antimicrobials such as beta-lactams should be administered to ensure optimal exposure at the infection site independently of the patient’s renal function because of the dilution effect 1. Two patterns of bactericidal activity have been described for antibiotics: time-dependent activity and concentration-dependent activity, and the efficacy of time-dependent antibacterial agents in severely ill patients is related primarily to the maintenance of supra-inhibitory concentrations, and therefore, multiple daily dosing or continuous infusion may be appropriate 1. On the other hand, some agents including aminoglycosides have concentration-dependent activity; therefore, for this antibiotic class, the entire daily dose should be administered in a once daily way (or with the lowest possible number of daily administrations) to achieve the highest peak plasma level and reduce the renal cortex exposure to aminoglycosides and reduces the risk of nephrotoxicity 1. In patients with uncomplicated ear infections, single doses have the same impact as multiple doses and post-operative antimicrobial therapy is not necessary if source control is adequate 1. In the setting of complicated ear infections, a short course of antibiotic therapy (3–5 days) after adequate source control is a reasonable option 1. However, in critically ill patients with ongoing sepsis, an individualized approach should be always mandatory and patient’s inflammatory response should be monitored regularly 1 and decisions to continue, narrow, or stop antimicrobial therapy must be made on the basis of clinician judgment. Patients who have ongoing signs of peritonitis or systemic illness beyond 5–7 days of antibiotic treatment normally warrant a diagnostic investigation to determine whether additional surgical intervention is necessary to address an ongoing uncontrolled source of infection or antimicrobial treatment failure 1. The prolonged and inappropriate use of antibiotics appears a key factor in the rapid rise of antimicrobial resistance worldwide over the past decade 1. A rational and appropriate use of antibiotics is particularly important both to optimize quality clinical care and to reduce selection pressure on resistant pathogens. Several strategies aiming at achieving optimal use of antimicrobial agents have been described, but it is essential that clinicians know antibiotic administration minimal requirements. Without these minimal requirements, clinicians worldwide will increase the likelihood of treatment failures and antibiotic resistance. In the context of ear infections, the choice of empiric antibiotic regimens should be based on the clinical condition of the patients, the individual risk for infection by resistant pathogens, and the local resistance epidemiology 1. The recent challenges of treating multidrug-resistant gram-negative infections, especially in critically ill patients, have renewed interest in the use of “old” antibiotics such as polymyxins and fosfomycin 1, now routinely used for treatment of MDR bacteria in critical ill patients. New antibiotics such as ceftolozone/tazobactam and ceftazidime/avibactam have been approved for treatment of complicated infections (in combination with metronidazole) including infection by ESBLs producing Enterobacteriaceae and P. aeruginosa 1. These antimicrobials will be valuable for treating infections caused by MDR gram-negative bacteria in order to preserve carbapenems. However, the use of these antibiotics should be limited to preserve their activity and prevent the emergence of resistance. In the setting of ear infections, empiric antimicrobial therapy should be started as soon as possible in patients with organ dysfunction and septic shock 1. The selection of a pharmacological agent with penetration to the site of presumed infection is necessary, and the pathophysiological and immunological status of the patient and the pharmacokinetic properties of the chosen drugs warrant consideration. In critically ill patients, higher than standard loading doses of hydrophilic antimicrobials such as beta-lactams should be administered to ensure optimal exposure at the infection site independently of the patient’s renal function because of the dilution effect 1. Two patterns of bactericidal activity have been described for antibiotics: time-dependent activity and concentration-dependent activity, and the efficacy of time-dependent antibacterial agents in severely ill patients is related primarily to the maintenance of supra-inhibitory concentrations, and therefore, multiple daily dosing or continuous infusion may be appropriate 1. On the other hand, some agents including aminoglycosides have concentration-dependent activity; therefore, for this antibiotic class, the entire daily dose should be administered in a once daily way (or with the lowest possible number of daily administrations) to achieve the highest peak plasma level and reduce the renal cortex exposure to aminoglycosides and reduces the risk of nephrotoxicity 1. In patients with uncomplicated ear infections, single doses have the same impact as multiple doses and post-operative antimicrobial therapy is not necessary if source control is adequate 1. In the setting of complicated ear infections, a short course of antibiotic therapy (3–5 days) after adequate source control is a reasonable option 1. However, in critically ill patients with ongoing sepsis, an individualized approach should be always mandatory and patient’s inflammatory response should be monitored regularly 1 and decisions to continue, narrow, or stop antimicrobial therapy must be made on the basis of clinician judgment. Patients who have ongoing signs of peritonitis or systemic illness beyond 5–7 days of antibiotic treatment normally warrant a diagnostic investigation to determine whether additional surgical intervention is necessary to address an ongoing uncontrolled source of infection or antimicrobial treatment failure 1. The prolonged and inappropriate use of antibiotics appears a key factor in the rapid rise of antimicrobial resistance worldwide over the past decade 1. A rational and appropriate use of antibiotics is particularly important both to optimize quality clinical care and to reduce selection pressure on resistant pathogens. Several strategies aiming at achieving optimal use of antimicrobial agents have been described, but it is essential that clinicians know antibiotic administration minimal requirements. Without these minimal requirements, clinicians worldwide will increase the likelihood of treatment failures and antibiotic resistance. In the context of ear infections, the choice of empiric antibiotic regimens should be based on the clinical condition of the patients, the individual risk for infection by resistant pathogens, and the local resistance epidemiology 1. The recent challenges of treating multidrug-resistant gram-negative infections, especially in critically ill patients, have renewed interest in the use of “old” antibiotics such as polymyxins and fosfomycin 1, now routinely used for treatment of MDR bacteria in critical ill patients. New antibiotics such as ceftolozone/tazobactam and ceftazidime/avibactam have been approved for treatment of complicated infections (in combination with metronidazole) including infection by ESBLs producing Enterobacteriaceae and P. aeruginosa 1. These antimicrobials will be valuable for treating infections caused by MDR gram-negative bacteria in order to preserve carbapenems. However, the use of these antibiotics should be limited to preserve their activity and prevent the emergence of resistance. In the setting of ear infections, empiric antimicrobial therapy should be started as soon as possible in patients with organ dysfunction and septic shock 1. The selection of a pharmacological agent with penetration to the site of presumed infection is necessary, and the pathophysiological and immunological status of the patient and the pharmacokinetic properties of the chosen drugs warrant consideration. In critically ill patients, higher than standard loading doses of hydrophilic antimicrobials such as beta-lactams should be administered to ensure optimal exposure at the infection site independently of the patient’s renal function because of the dilution effect 1. Two patterns of bactericidal activity have been described for antibiotics: time-dependent activity and concentration-dependent activity, and the efficacy of time-dependent antibacterial agents in severely ill patients is related primarily to the maintenance of supra-inhibitory concentrations, and therefore, multiple daily dosing or continuous infusion may be appropriate 1. On the other hand, some agents including aminoglycosides have concentration-dependent activity; therefore, for this antibiotic class, the entire daily dose should be administered in a once daily way (or with the lowest possible number of daily administrations) to achieve the highest peak plasma level and reduce the renal cortex exposure to aminoglycosides and reduces the risk of nephrotoxicity 1. In patients with uncomplicated ear infections, single doses have the same impact as multiple doses and post-operative antimicrobial therapy is not necessary if source control is adequate 1. In the setting of complicated ear infections, a short course of antibiotic therapy (3–5 days) after adequate source control is a reasonable option 1. However, in critically ill patients with ongoing sepsis, an individualized approach should be always mandatory and patient’s inflammatory response should be monitored regularly 1 and decisions to continue, narrow, or stop antimicrobial therapy must be made on the basis of clinician judgment. Patients who have ongoing signs of peritonitis or systemic illness beyond 5–7 days of antibiotic treatment normally warrant a diagnostic investigation to determine whether additional surgical intervention is necessary to address an ongoing uncontrolled source of infection or antimicrobial treatment failure 1. The prolonged and inappropriate use of antibiotics appears a key factor in the rapid rise of antimicrobial resistance worldwide over the past decade 1. A rational and appropriate use of antibiotics is particularly important both to optimize quality clinical care and to reduce selection pressure on resistant pathogens. Several strategies aiming at achieving optimal use of antimicrobial agents have been described, but it is essential that clinicians know antibiotic administration minimal requirements. Without these minimal requirements, clinicians worldwide will increase the likelihood of treatment failures and antibiotic resistance. In the context of ear infections, the choice of empiric antibiotic regimens should be based on the clinical condition of the patients, the individual risk for infection by resistant pathogens, and the local resistance epidemiology 1. The recent challenges of treating multidrug-resistant gram-negative infections, especially in critically ill patients, have renewed interest in the use of “old” antibiotics such as polymyxins and fosfomycin 1, now routinely used for treatment of MDR bacteria in critical ill patients. New antibiotics such as ceftolozone/tazobactam and ceftazidime/avibactam have been approved for treatment of complicated infections (in combination with metronidazole) including infection by ESBLs producing Enterobacteriaceae and P. aeruginosa 1. These antimicrobials will be valuable for treating infections caused by MDR gram-negative bacteria in order to preserve carbapenems. However, the use of these antibiotics should be limited to preserve their activity and prevent the emergence of resistance. In the setting of ear infections, empiric antimicrobial therapy should be started as soon as possible in patients with organ dysfunction and septic shock 1. The selection of a pharmacological agent with penetration to the site of presumed infection is necessary, and the pathophysiological and immunological status of the patient and the pharmacokinetic properties of the chosen drugs warrant consideration. In critically ill patients, higher than standard loading doses of hydrophilic antimicrobials such as beta-lactams should be administered to ensure optimal exposure at the infection site independently of the patient’s renal function because of the dilution effect 1. Two patterns of bactericidal activity have been described for antibiotics: time-dependent activity and concentration-dependent activity, and the efficacy of time-dependent antibacterial agents in severely ill patients is related primarily to the maintenance of supra-inhibitory concentrations, and therefore, multiple daily dosing or continuous infusion may be appropriate 1. On the other hand, some agents including aminoglycosides have concentration-dependent activity; therefore, for this antibiotic class, the entire daily dose should be administered in a once daily way (or with the lowest possible number of daily administrations) to achieve the highest peak plasma level and reduce the renal cortex exposure to aminoglycosides and reduces the risk of nephrotoxicity 1. In patients with uncomplicated ear infections, single doses have the same impact as multiple doses and post-operative antimicrobial therapy is not necessary if source control is adequate 1. In the setting of complicated ear infections, a short course of antibiotic therapy (3–5 days) after adequate source control is a reasonable option 1. However, in critically ill patients with ongoing sepsis, an individualized approach should be always mandatory and patient’s inflammatory response should be monitored regularly 1 and decisions to continue, narrow, or stop antimicrobial therapy must be made on the basis of clinician judgment. Patients who have ongoing signs of peritonitis or systemic illness beyond 5–7 days of antibiotic treatment normally warrant a diagnostic investigation to determine whether additional surgical intervention is necessary to address an ongoing uncontrolled source of infection or antimicrobial treatment failure 1. The prolonged and inappropriate use of antibiotics appears a key factor in the rapid rise of antimicrobial resistance worldwide over the past decade 1. A rational and appropriate use of antibiotics is particularly important both to optimize quality clinical care and to reduce selection pressure on resistant pathogens. Several strategies aiming at achieving optimal use of antimicrobial agents have been described, but it is essential that clinicians know antibiotic administration minimal requirements. Without these minimal requirements, clinicians worldwide will increase the likelihood of treatment failures and antibiotic resistance. In the context of ear infections, the choice of empiric antibiotic regimens should be based on the clinical condition of the patients, the individual risk for infection by resistant pathogens, and the local resistance epidemiology 1. The recent challenges of treating multidrug-resistant gram-negative infections, especially in critically ill patients, have renewed interest in the use of “old” antibiotics such as polymyxins and fosfomycin 1, now routinely used for treatment of MDR bacteria in critical ill patients. New antibiotics such as ceftolozone/tazobactam and ceftazidime/avibactam have been approved for treatment of complicated infections (in combination with metronidazole) including infection by ESBLs producing Enterobacteriaceae and P. aeruginosa 1. These antimicrobials will be valuable for treating infections caused by MDR gram-negative bacteria in order to preserve carbapenems. However, the use of these antibiotics should be limited to preserve their activity and prevent the emergence of resistance. In the setting of ear infections, empiric antimicrobial therapy should be started as soon as possible in patients with organ dysfunction and septic shock 1. The selection of a pharmacological agent with penetration to the site of presumed infection is necessary, and the pathophysiological and immunological status of the patient and the pharmacokinetic properties of the chosen drugs warrant consideration. In critically ill patients, higher than standard loading doses of hydrophilic antimicrobials such as beta-lactams should be administered to ensure optimal exposure at the infection site independently of the patient’s renal function because of the dilution effect 1. Two patterns of bactericidal activity have been described for antibiotics: time-dependent activity and concentration-dependent activity, and the efficacy of time-dependent antibacterial agents in severely ill patients is related primarily to the maintenance of supra-inhibitory concentrations, and therefore, multiple daily dosing or continuous infusion may be appropriate 1. On the other hand, some agents including aminoglycosides have concentration-dependent activity; therefore, for this antibiotic class, the entire daily dose should be administered in a once daily way (or with the lowest possible number of daily administrations) to achieve the highest peak plasma level and reduce the renal cortex exposure to aminoglycosides and reduces the risk of nephrotoxicity 1. In patients with uncomplicated ear infections, single doses have the same impact as multiple doses and post-operative antimicrobial therapy is not necessary if source control is adequate 1. In the setting of complicated ear infections, a short course of antibiotic therapy (3–5 days) after adequate source control is a reasonable option 1. However, in critically ill patients with ongoing sepsis, an individualized approach should be always mandatory and patient’s inflammatory response should be monitored regularly 1 and decisions to continue, narrow, or stop antimicrobial therapy must be made on the basis of clinician judgment. Patients who have ongoing signs of peritonitis or systemic illness beyond 5–7 days of antibiotic treatment normally warrant a diagnostic investigation to determine whether additional surgical intervention is necessary to address an ongoing uncontrolled source of infection or antimicrobial treatment failure 1. The prolonged and inappropriate use of antibiotics appears a key factor in the rapid rise of antimicrobial resistance worldwide over the past decade 1. A rational and appropriate use of antibiotics is particularly important both to optimize quality clinical care and to reduce selection pressure on resistant pathogens. Several strategies aiming at achieving optimal use of antimicrobial agents have been described, but it is essential that clinicians know antibiotic administration minimal requirements. Without these minimal requirements, clinicians worldwide will increase the likelihood of treatment failures and antibiotic resistance. In the context of ear infections, the choice of empiric antibiotic regimens should be based on the clinical condition of the patients, the individual risk for infection by resistant pathogens, and the local resistance epidemiology 1. The recent challenges of treating multidrug-resistant gram-negative infections, especially in critically ill patients, have renewed interest in the use of “old” antibiotics such as polymyxins and fosfomycin 1, now routinely used for treatment of MDR bacteria in critical ill patients. New antibiotics such as ceftolozone/tazobactam and ceftazidime/avibactam have been approved for treatment of complicated infections (in combination with metronidazole) including infection by ESBLs producing Enterobacteriaceae and P. aeruginosa 1. These antimicrobials will be valuable for treating infections caused by MDR gram-negative bacteria in order to preserve carbapenems. However, the use of these antibiotics should be limited to preserve their activity and prevent the emergence of resistance. In the setting of ear infections, empiric antimicrobial therapy should be started as soon as possible in patients with organ dysfunction and septic shock 1. The selection of a pharmacological agent with penetration to the site of presumed infection is necessary, and the pathophysiological and immunological status of the patient and the pharmacokinetic properties of the chosen drugs warrant consideration. In critically ill patients, higher than standard loading doses of hydrophilic antimicrobials such as beta-lactams should be administered to ensure optimal exposure at the infection site independently of the patient’s renal function because of the dilution effect 1. Two patterns of bactericidal activity have been described for antibiotics: time-dependent activity and concentration-dependent activity, and the efficacy of time-dependent antibacterial agents in severely ill patients is related primarily to the maintenance of supra-inhibitory concentrations, and therefore, multiple daily dosing or continuous infusion may be appropriate 1. On the other hand, some agents including aminoglycosides have concentration-dependent activity; therefore, for this antibiotic class, the entire daily dose should be administered in a once daily way (or with the lowest possible number of daily administrations) to achieve the highest peak plasma level and reduce the renal cortex exposure to aminoglycosides and reduces the risk of nephrotoxicity 1. In patients with uncomplicated ear infections, single doses have the same impact as multiple doses and post-operative antimicrobial therapy is not necessary if source control is adequate 1. In the setting of complicated ear infections, a short course of antibiotic therapy (3–5 days) after adequate source control is a reasonable option 1. However, in critically ill patients with ongoing sepsis, an individualized approach should be always mandatory and patient’s inflammatory response should be monitored regularly 1 and decisions to continue, narrow, or stop antimicrobial therapy must be made on the basis of clinician judgment. Patients who have ongoing signs of peritonitis or systemic illness beyond 5–7 days of antibiotic treatment normally warrant a diagnostic investigation to determine whether additional surgical intervention is necessary to address an ongoing uncontrolled source of infection or antimicrobial treatment failure 1. The prolonged and inappropriate use of antibiotics appears a key factor in the rapid rise of antimicrobial resistance worldwide over the past decade 1. A rational and appropriate use of antibiotics is particularly important both to optimize quality clinical care and to reduce selection pressure on resistant pathogens. Several strategies aiming at achieving optimal use of antimicrobial agents have been described, but it is essential that clinicians know antibiotic administration minimal requirements. Without these minimal requirements, clinicians worldwide will increase the likelihood of treatment failures and antibiotic resistance. In the context of ear infections, the choice of empiric antibiotic regimens should be based on the clinical condition of the patients, the individual risk for infection by resistant pathogens, and the local resistance epidemiology 1. The recent challenges of treating multidrug-resistant gram-negative infections, especially in critically ill patients, have renewed interest in the use of “old” antibiotics such as polymyxins and fosfomycin 1, now routinely used for treatment of MDR bacteria in critical ill patients. New antibiotics such as ceftolozone/tazobactam and ceftazidime/avibactam have been approved for treatment of complicated infections (in combination with metronidazole) including infection by ESBLs producing Enterobacteriaceae and P. aeruginosa 1. These antimicrobials will be valuable for treating infections caused by MDR gram-negative bacteria in order to preserve carbapenems. However, the use of these antibiotics should be limited to preserve their activity and prevent the emergence of resistance. In the setting of ear infections, empiric antimicrobial therapy should be started as soon as possible in patients with organ dysfunction and septic shock 1. The selection of a pharmacological agent with penetration to the site of presumed infection is necessary, and the pathophysiological and immunological status of the patient and the pharmacokinetic properties of the chosen drugs warrant consideration. In critically ill patients, higher than standard loading doses of hydrophilic antimicrobials such as beta-lactams should be administered to ensure optimal exposure at the infection site independently of the patient’s renal function because of the dilution effect 1. Two patterns of bactericidal activity have been described for antibiotics: time-dependent activity and concentration-dependent activity, and the efficacy of time-dependent antibacterial agents in severely ill patients is related primarily to the maintenance of supra-inhibitory concentrations, and therefore, multiple daily dosing or continuous infusion may be appropriate 1. On the other hand, some agents including aminoglycosides have concentration-dependent activity; therefore, for this antibiotic class, the entire daily dose should be administered in a once daily way (or with the lowest possible number of daily administrations) to achieve the highest peak plasma level and reduce the renal cortex exposure to aminoglycosides and reduces the risk of nephrotoxicity 1. In patients with uncomplicated ear infections, single doses have the same impact as multiple doses and post-operative antimicrobial therapy is not necessary if source control is adequate 1. In the setting of complicated ear infections, a short course of antibiotic therapy (3–5 days) after adequate source control is a reasonable option 1. However, in critically ill patients with ongoing sepsis, an individualized approach should be always mandatory and patient’s inflammatory response should be monitored regularly 1 and decisions to continue, narrow, or stop antimicrobial therapy must be made on the basis of clinician judgment. Patients who have ongoing signs of peritonitis or systemic illness beyond 5–7 days of antibiotic treatment normally warrant a diagnostic investigation to determine whether additional surgical intervention is necessary to address an ongoing uncontrolled source of infection or antimicrobial treatment failure 1. The prolonged and inappropriate use of antibiotics appears a key factor in the rapid rise of antimicrobial resistance worldwide over the past decade 1. A rational and appropriate use of antibiotics is particularly important both to optimize quality clinical care and to reduce selection pressure on resistant pathogens. Several strategies aiming at achieving optimal use of antimicrobial agents have been described, but it is essential that clinicians know antibiotic administration minimal requirements. Without these minimal requirements, clinicians worldwide will increase the likelihood of treatment failures and antibiotic resistance. In the context of ear infections, the choice of empiric antibiotic regimens should be based on the clinical condition of the patients, the individual risk for infection by resistant pathogens, and the local resistance epidemiology 1. The recent challenges of treating multidrug-resistant gram-negative infections, especially in critically ill patients, have renewed interest in the use of “old” antibiotics such as polymyxins and fosfomycin 1, now routinely used for treatment of MDR bacteria in critical ill patients. New antibiotics such as ceftolozone/tazobactam and ceftazidime/avibactam have been approved for treatment of complicated infections (in combination with metronidazole) including infection by ESBLs producing Enterobacteriaceae and P. aeruginosa 1. These antimicrobials will be valuable for treating infections caused by MDR gram-negative bacteria in order to preserve carbapenems. However, the use of these antibiotics should be limited to preserve their activity and prevent the emergence of resistance. In the setting of ear infections, empiric antimicrobial therapy should be started as soon as possible in patients with organ dysfunction and septic shock 1. The selection of a pharmacological agent with penetration to the site of presumed infection is necessary, and the pathophysiological and immunological status of the patient and the pharmacokinetic properties of the chosen drugs warrant consideration. In critically ill patients, higher than standard loading doses of hydrophilic antimicrobials such as beta-lactams should be administered to ensure optimal exposure at the infection site independently of the patient’s renal function because of the dilution effect 1. Two patterns of bactericidal activity have been described for antibiotics: time-dependent activity and concentration-dependent activity, and the efficacy of time-dependent antibacterial agents in severely ill patients is related primarily to the maintenance of supra-inhibitory concentrations, and therefore, multiple daily dosing or continuous infusion may be appropriate 1. On the other hand, some agents including aminoglycosides have concentration-dependent activity; therefore, for this antibiotic class, the entire daily dose should be administered in a once daily way (or with the lowest possible number of daily administrations) to achieve the highest peak plasma level and reduce the renal cortex exposure to aminoglycosides and reduces the risk of nephrotoxicity 1. In patients with uncomplicated ear infections, single doses have the same impact as multiple doses and post-operative antimicrobial therapy is not necessary if source control is adequate 1. In the setting of complicated ear infections, a short course of antibiotic therapy (3–5 days) after adequate source control is a reasonable option 1. However, in critically ill patients with ongoing sepsis, an individualized approach should be always mandatory and patient’s inflammatory response should be monitored regularly 1 and decisions to continue, narrow, or stop antimicrobial therapy must be made on the basis of clinician judgment. Patients who have ongoing signs of peritonitis or systemic illness beyond 5–7 days of antibiotic treatment normally warrant a diagnostic investigation to determine whether additional surgical intervention is necessary to address an ongoing uncontrolled source of infection or antimicrobial treatment failure 1. The prolonged and inappropriate use of antibiotics appears a key factor in the rapid rise of antimicrobial resistance worldwide over the past decade 1. A rational and appropriate use of antibiotics is particularly important both to optimize quality clinical care and to reduce selection pressure on resistant pathogens. Several strategies aiming at achieving optimal use of antimicrobial agents have been described, but it is essential that clinicians know antibiotic administration minimal requirements. Without these minimal requirements, clinicians worldwide will increase the likelihood of treatment failures and antibiotic resistance. In the context of ear infections, the choice of empiric antibiotic regimens should be based on the clinical condition of the patients, the individual risk for infection by resistant pathogens, and the local resistance epidemiology 1. The recent challenges of treating multidrug-resistant gram-negative infections, especially in critically ill patients, have renewed interest in the use of “old” antibiotics such as polymyxins and fosfomycin 1, now routinely used for treatment of MDR bacteria in critical ill patients. New antibiotics such as ceftolozone/tazobactam and ceftazidime/avibactam have been approved for treatment of complicated infections (in combination with metronidazole) including infection by ESBLs producing Enterobacteriaceae and P. aeruginosa 1. These antimicrobials will be valuable for treating infections caused by MDR gram-negative bacteria in order to preserve carbapenems. However, the use of these antibiotics should be limited to preserve their activity and prevent the emergence of resistance. In the setting of ear infections, empiric antimicrobial therapy should be started as soon as possible in patients with organ dysfunction and septic shock 1. The selection of a pharmacological agent with penetration to the site of presumed infection is necessary, and the pathophysiological and immunological status of the patient and the pharmacokinetic properties of the chosen drugs warrant consideration. In critically ill patients, higher than standard loading doses of hydrophilic antimicrobials such as beta-lactams should be administered to ensure optimal exposure at the infection site independently of the patient’s renal function because of the dilution effect 1. Two patterns of bactericidal activity have been described for antibiotics: time-dependent activity and concentration-dependent activity, and the efficacy of time-dependent antibacterial agents in severely ill patients is related primarily to the maintenance of supra-inhibitory concentrations, and therefore, multiple daily dosing or continuous infusion may be appropriate 1. On the other hand, some agents including aminoglycosides have concentration-dependent activity; therefore, for this antibiotic class, the entire daily dose should be administered in a once daily way (or with the lowest possible number of daily administrations) to achieve the highest peak plasma level and reduce the renal cortex exposure to aminoglycosides and reduces the risk of nephrotoxicity 1. In patients with uncomplicated ear infections, single doses have the same impact as multiple doses and post-operative antimicrobial therapy is not necessary if source control is adequate 1. In the setting of complicated ear infections, a short course of antibiotic therapy (3–5 days) after adequate source control is a reasonable option 1. However, in critically ill patients with ongoing sepsis, an individualized approach should be always mandatory and patient’s inflammatory response should be monitored regularly 1 and decisions to continue, narrow, or stop antimicrobial therapy must be made on the basis of clinician judgment. Patients who have ongoing signs of peritonitis or systemic illness beyond 5–7 days of antibiotic treatment normally warrant a diagnostic investigation to determine whether additional surgical intervention is necessary to address an ongoing uncontrolled source of infection or antimicrobial treatment failure 1. The prolonged and inappropriate use of antibiotics appears a key factor in the rapid rise of antimicrobial resistance worldwide over the past decade 1. A rational and appropriate use of antibiotics is particularly important both to optimize quality clinical care and to reduce selection pressure on resistant pathogens. Several strategies aiming at achieving optimal use of antimicrobial agents have been described, but it is essential that clinicians know antibiotic administration minimal requirements. Without these minimal requirements, clinicians worldwide will increase the likelihood of treatment failures and antibiotic resistance. In the context of ear infections, the choice of empiric antibiotic regimens should be based on the clinical condition of the patients, the individual risk for infection by resistant pathogens, and the local resistance epidemiology 1. The recent challenges of treating multidrug-resistant gram-negative infections, especially in critically ill patients, have renewed interest in the use of “old” antibiotics such as polymyxins and fosfomycin 1, now routinely used for treatment of MDR bacteria in critical ill patients. New antibiotics such as ceftolozone/tazobactam and ceftazidime/avibactam have been approved for treatment of complicated infections (in combination with metronidazole) including infection by ESBLs producing Enterobacteriaceae and P. aeruginosa 1. These antimicrobials will be valuable for treating infections caused by MDR gram-negative bacteria in order to preserve carbapenems. However, the use of these antibiotics should be limited to preserve their activity and prevent the emergence of resistance. In the setting of ear infections, empiric antimicrobial therapy should be started as soon as possible in patients with organ dysfunction and septic shock 1. The selection of a pharmacological agent with penetration to the site of presumed infection is necessary, and the pathophysiological and immunological status of the patient and the pharmacokinetic properties of the chosen drugs warrant consideration. In critically ill patients, higher than standard loading doses of hydrophilic antimicrobials such as beta-lactams should be administered to ensure optimal exposure at the infection site independently of the patient’s renal function because of the dilution effect 1. Two patterns of bactericidal activity have been described for antibiotics: time-dependent activity and concentration-dependent activity, and the efficacy of time-dependent antibacterial agents in severely ill patients is related primarily to the maintenance of supra-inhibitory concentrations, and therefore, multiple daily dosing or continuous infusion may be appropriate 1. On the other hand, some agents including aminoglycosides have concentration-dependent activity; therefore, for this antibiotic class, the entire daily dose should be administered in a once daily way (or with the lowest possible number of daily administrations) to achieve the highest peak plasma level and reduce the renal cortex exposure to aminoglycosides and reduces the risk of nephrotoxicity 1. In patients with uncomplicated ear infections, single doses have the same impact as multiple doses and post-operative antimicrobial therapy is not necessary if source control is adequate 1. In the setting of complicated ear infections, a short course of antibiotic therapy (3–5 days) after adequate source control is a reasonable option 1. However, in critically ill patients with ongoing sepsis, an individualized approach should be always mandatory and patient’s inflammatory response should be monitored regularly 1 and decisions to continue, narrow, or stop antimicrobial therapy must be made on the basis of clinician judgment. Patients who have ongoing signs of peritonitis or systemic illness beyond 5–7 days of antibiotic treatment normally warrant a diagnostic investigation to determine whether additional surgical intervention is necessary to address an ongoing uncontrolled source of infection or antimicrobial treatment failure 1. The prolonged and inappropriate use of antibiotics appears a key factor in the rapid rise of antimicrobial resistance worldwide over the past decade 1. A rational and appropriate use of antibiotics is particularly important both to optimize quality clinical care and to reduce selection pressure on resistant pathogens. Several strategies aiming at achieving optimal use of antimicrobial agents have been described, but it is essential that clinicians know antibiotic administration minimal requirements. Without these minimal requirements, clinicians worldwide will increase the likelihood of treatment failures and antibiotic resistance. In the context of ear infections, the choice of empiric antibiotic regimens should be based on the clinical condition of the patients, the individual risk for infection by resistant pathogens, and the local resistance epidemiology 1. The recent challenges of treating multidrug-resistant gram-negative infections, especially in critically ill patients, have renewed interest in the use of “old” antibiotics such as polymyxins and fosfomycin 1, now routinely used for treatment of MDR bacteria in critical ill patients. New antibiotics such as ceftolozone/tazobactam and ceftazidime/avibactam have been approved for treatment of complicated infections (in combination with metronidazole) including infection by ESBLs producing Enterobacteriaceae and P. aeruginosa 1. These antimicrobials will be valuable for treating infections caused by MDR gram-negative bacteria in order to preserve carbapenems. However, the use of these antibiotics should be limited to preserve their activity and prevent the emergence of resistance. In the setting of ear infections, empiric antimicrobial therapy should be started as soon as possible in patients with organ dysfunction and septic shock 1. The selection of a pharmacological agent with penetration to the site of presumed infection is necessary, and the pathophysiological and immunological status of the patient and the pharmacokinetic properties of the chosen drugs warrant consideration. In critically ill patients, higher than standard loading doses of hydrophilic antimicrobials such as beta-lactams should be administered to ensure optimal exposure at the infection site independently of the patient’s renal function because of the dilution effect 1. Two patterns of bactericidal activity have been described for antibiotics: time-dependent activity and concentration-dependent activity, and the efficacy of time-dependent antibacterial agents in severely ill patients is related primarily to the maintenance of supra-inhibitory concentrations, and therefore, multiple daily dosing or continuous infusion may be appropriate 1. On the other hand, some agents including aminoglycosides have concentration-dependent activity; therefore, for this antibiotic class, the entire daily dose should be administered in a once daily way (or with the lowest possible number of daily administrations) to achieve the highest peak plasma level and reduce the renal cortex exposure to aminoglycosides and reduces the risk of nephrotoxicity 1. In patients with uncomplicated ear infections, single doses have the same impact as multiple doses and post-operative antimicrobial therapy is not necessary if source control is adequate 1. In the setting of complicated ear infections, a short course of antibiotic therapy (3–5 days) after adequate source control is a reasonable option 1. However, in critically ill patients with ongoing sepsis, an individualized approach should be always mandatory and patient’s inflammatory response should be monitored regularly 1 and decisions to continue, narrow, or stop antimicrobial therapy must be made on the basis of clinician judgment. Patients who have ongoing signs of peritonitis or systemic illness beyond 5–7 days of antibiotic treatment normally warrant a diagnostic investigation to determine whether additional surgical intervention is necessary to address an ongoing uncontrolled source of infection or antimicrobial treatment failure 1. The prolonged and inappropriate use of antibiotics appears a key factor in the rapid rise of antimicrobial resistance worldwide over the past decade 1. A rational and appropriate use of antibiotics is particularly important both to optimize quality clinical care and to reduce selection pressure on resistant pathogens. Several strategies aiming at achieving optimal use of antimicrobial agents have been described, but it is essential that clinicians know antibiotic administration minimal requirements. Without these minimal requirements, clinicians worldwide will increase the likelihood of treatment failures and antibiotic resistance. In the context of ear infections, the choice of empiric antibiotic regimens should be based on the clinical condition of the patients, the individual risk for infection by resistant pathogens, and the local resistance epidemiology 1. The recent challenges of treating multidrug-resistant gram-negative infections, especially in critically ill patients, have renewed interest in the use of “old” antibiotics such as polymyxins and fosfomycin 1, now routinely used for treatment of MDR bacteria in critical ill patients. New antibiotics such as ceftolozone/tazobactam and ceftazidime/avibactam have been approved for treatment of complicated infections (in combination with metronidazole) including infection by ESBLs producing Enterobacteriaceae and P. aeruginosa 1. These antimicrobials will be valuable for treating infections caused by MDR gram-negative bacteria in order to preserve carbapenems. However, the use of these antibiotics should be limited to preserve their activity and prevent the emergence of resistance. In the setting of ear infections, empiric antimicrobial therapy should be started as soon as possible in patients with organ dysfunction and septic shock 1. The selection of a pharmacological agent with penetration to the site of presumed infection is necessary, and the pathophysiological and immunological status of the patient and the pharmacokinetic properties of the chosen drugs warrant consideration. In critically ill patients, higher than standard loading doses of hydrophilic antimicrobials such as beta-lactams should be administered to ensure optimal exposure at the infection site independently of the patient’s renal function because of the dilution effect 1. Two patterns of bactericidal activity have been described for antibiotics: time-dependent activity and concentration-dependent activity, and the efficacy of time-dependent antibacterial agents in severely ill patients is related primarily to the maintenance of supra-inhibitory concentrations, and therefore, multiple daily dosing or continuous infusion may be appropriate 1. On the other hand, some agents including aminoglycosides have concentration-dependent activity; therefore, for this antibiotic class, the entire daily dose should be administered in a once daily way (or with the lowest possible number of daily

From the Research

Klebcilla Ear Infection

• There is limited information available on "Klebcilla" ear infections, but it is possible that it refers to an infection caused by Klebsiella pneumoniae, a type of bacteria.
• According to a study published in 2006 2, Klebsiella pneumoniae can cause necrotizing external otitis, a potentially life-threatening infection involving the temporal and adjacent bones.
• The study suggests that synergistic antibiotic therapy using a third-generation cephalosporin or quinolone (ciprofloxacin), accompanied by metronidazole, and even a short-term aminoglycoside may be effective in treating severe Klebsiella-induced necrotizing external otitis.

Treatment Options

• Ciprofloxacin has been shown to be effective in treating otitis externa, a type of ear infection, in a study published in 1993 3.
• Levofloxacin, a fluoroquinolone antibacterial agent, has a broad spectrum of activity against Gram-positive and Gram-negative bacteria, including Pseudomonas aeruginosa, which is often associated with ear infections 4.
• Combination therapy using levofloxacin or ciprofloxacin with other antibiotics, such as ceftazidime or amikacin, may be effective in treating Pseudomonas aeruginosa infections, according to a study published in 2004 5.

Current Treatment Guidelines

• The current choices of antibiotic treatment for Pseudomonas aeruginosa infections, including those affecting the ear, are limited and often require combination therapy or novel antibiotics, as discussed in a review published in 2020 6.
• Antimicrobial stewardship is essential to preserve the effectiveness of current antibiotics and prevent the development of resistance.